Currently, the stock price of Alaunos Therapeutics Inc. (TCRT) is $0.13. In the most recent trading session, the stock underwent a significant upswing, peaking at $0.1275 after opening at $0.123. The stock touched a low of $0.122 before closing at $0.12.
Alaunos Therapeutics Inc.’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $3.73 on 09/15/22, and the lowest price during that time was $0.12, recorded on 08/22/23.
52-week price history of TCRT Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Alaunos Therapeutics Inc.’s current trading price is -96.54% away from its 52-week high, while its distance from the 52-week low is 7.58%. The stock’s price range during this period has fluctuated between $0.12 and $3.73. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.48 million for the day, which was evidently lower than the average daily volume of 1.85 million over the last three months.
Financial Performance and Market Capitalization
Alaunos Therapeutics Inc. (TCRT) has experienced a quarterly decline of -71.56% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 32.43M and boasts a workforce of 34 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4216, with a change in price of -0.3792. Similarly, Alaunos Therapeutics Inc. recorded 1,390,622 in trading volume during the last 100 days, posting a change of -74.35%.
TCRT Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TCRT stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
TCRT Stock Stochastic Average
The raw stochastic average for Alaunos Therapeutics Inc. over the last 50 days is presently at 2.72%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 11.03%. Further, the company’s Stochastic %K and %D values for the last 20 days were 5.65% and 3.48%, respectively.
TCRT Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price decrease of -80.11%. However, over the past six months, we’ve seen a stronger performance of -74.05%. The price of TCRT leaped by -7.12% over the last 30 days. And in the last five days, it has fallen by -2.64%.